Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
ACR, arthroplasty, arthroscopy, attorney, Bachelor, Biomedical, cashlessly, Cherevka, Chico, Chilcott, consecutive, cyber, cybersecurity, deficiency, Distinguishing, Dodd, donor, epidemic, EPS, exact, Frank, gradual, greatest, Guide, headcount, Hedging, highest, Holli, incomplete, infrastructure, King, KMPG, landscape, leaner, London, malware, Marwick, median, memo, Metrix, nephropathywith, Noncontrolling, Nonpublic, OAK, OARSI, OLE, OMERACT, ordinary, oversaw, Parenteral, PCAOB, Peat, PEO, phishing, platelet, progenitor, Radiology, reallocate, regain, regime, remeasurement, repeat, round, Russia, settle, simpler, simplicity, sixteen, solid, standing, streamline, symptomatic, Terker, thought, timeline, upgrade, VEGF, Villanova
Removed:
accurately, aid, amortized, Andersen, arose, Arthur, Atrix, biomarker, biotech, cAMP, cancelled, CBER, complaint, concentrated, consolidated, consultation, CRT, CytoDyn, detect, deteriorate, discounted, divided, domestically, Eligard, emerging, estimation, flow, fraction, HIV, incapable, instrumental, Knoll, KRG, light, Linden, LLP, LP, machinery, MedTech, MKT, nephropathy, PHSA, played, prevention, Prof, protecting, purification, QLT, retirement, separately, separation, SeraCare, servicesare, slightly, specialty, Subtopic, supporting, traded, TRLLC, underwriter, underwritten
Filing tables
Filing exhibits
AMPE similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Ampio Pharmaceuticals, Inc.’s Registration Statements on Form S-8 (File Nos. 333-186077, 333-181626, 333-175161, and 333-194428) and Form S-3 (File No. 333-217094) of our report dated March 6, 2018, relating to the financial statements, which includes an explanatory paragraph regarding the substantial doubt about Ampio Pharmaceuticals, Inc.’s ability to continue as a going concern, which appears in this Annual Report on Form 10-K.
/s/ EKS&H LLLP
March 6, 2018
Denver, Colorado